Max Strength Congestion Relief (Phenylephrine Hydrochloride)

Phenylephrine hydrochloride is a selective alpha‑1 adrenergic receptor agonist. By activating these receptors on nasal mucosal blood vessels, it causes vasoconstriction, which decreases mucosal edema and opens the nasal airway, providing short‑term decongestion.

The appropriate dose is determined by a prescriber or according to the product label. Patients should follow the specific instructions provided by their healthcare professional and never exceed the recommended amount.

Safety data for phenylephrine hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Phenylephrine is a sympathomimetic decongestant, similar in action to pseudoephedrine but generally considered to have a milder systemic effect. It is available over the counter in many regions, whereas some alternatives may require prescription or have different safety profiles.

Store Max Strength Congestion Relief at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and keep out of reach of children.

The product is taken orally, typically with a full glass of water. It should be swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include elevated blood pressure, cardiac arrhythmias, myocardial infarction, severe allergic reactions such as anaphylaxis, and rare cerebrovascular events. Patients experiencing these symptoms should seek immediate medical attention.

Individuals with uncontrolled hypertension, severe coronary artery disease, known hypersensitivity to phenylephrine, or those taking monoamine oxidase inhibitors should avoid this product unless advised otherwise by a qualified healthcare professional.